Lv3
210 积分 2025-03-25 加入
A novel safer CD19CAR with shRNA interference of IFN-γ can reduce multiple cytokine levels without significantly compromising its killing efficacy
13天前
已完结
Nonclinical development of RNA cancer vaccines: proof-of-concept testing, safety study design, and future prospects
1个月前
已完结
Non-clinical development of cancer vaccines: Regulatory considerations
1个月前
已完结
Design and preclinical assessment of mRNA-1345 prefusion F glycoprotein-encoding mRNA vaccine for respiratory syncytial virus
2个月前
已完结
CAR T-cell therapy in SLE: A systematic review
2个月前
已完结
Critical Considerations of mRNA-LNPs Technology for CAR-T Therapy: Components, Payloads and Emerging Horizons
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
2个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
2个月前
已完结
In vivo CAR engineering for immunotherapy
3个月前
已完结
皖公网安备34019202002308
